Salubris Biotherapeutics
Pre-clinicalDevelops novel antibody-based therapeutics for oncology and autoimmune diseases.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $70M
About
Develops novel antibody-based therapeutics for oncology and autoimmune diseases.
Biologics
Funding History
2Total raised:$70M
Series B$50MJun 15, 2020
Series A$20MJun 15, 2018